Genetic alterations of TP53 and OTX2 indicate increased risk of relapse in WNT medulloblastomas: "it's a numbers game"-implications for WNT medulloblastoma dose-reduction clinical trials

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)145-147
Number of pages3
JournalActa Neuropathologica
Volume145
Issue number1
Early online date20 Nov 2022
DOIs
Publication statusPublished - Jan 2023

Cite this